Steward Partners Investment Advisory’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-50
Closed -$9.96K 3601
2023
Q3
$9.96K Hold
50
﹤0.01% 2604
2023
Q2
$14.3K Hold
50
﹤0.01% 2444
2023
Q1
$10.8K Sell
50
-800
-94% -$156K ﹤0.01% 2510
2022
Q4
$175K Buy
850
+800
+1,600% +$202K ﹤0.01% 1300
2022
Q3
$14K Hold
50
﹤0.01% 2400
2022
Q2
$10K Hold
50
﹤0.01% 2531
2022
Q1
$10K Buy
+50
New +$8.24K ﹤0.01% 2681
2021
Q4
Sell
-500
Closed -$103K 3353
2021
Q3
$103K Buy
+500
New +$98.2K ﹤0.01% 1536

Other funds holding SWAV

Steward Partners Investment Advisory's SWAV Position: Q4 2023 in Review

Steward Partners Investment Advisory sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q4 2023, closing a stake of 50 shares — an estimated $9.96K sold.

Steward Partners Investment Advisory first reported a position in SWAV in Q3 2021 and held it in 8 quarters. The position peaked at $175K in Q4 2022. 427 funds tracked by Wall St. Rank hold SWAV as of Q4 2023.

  • Steward Partners Investment Advisory reported no remaining Shockwave Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 50 Shockwave Medical, Inc. Common Stock shares in Q4 2023, an estimated $9.96K.
  • Steward Partners Investment Advisory first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2021 and held it in 8 quarters.
  • Steward Partners Investment Advisory's Shockwave Medical, Inc. Common Stock position peaked at $175K in Q4 2022.
  • 427 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q4 2023.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2023, filed 12 Feb 2024.